https://www.selleckchem.com/pr....oducts/3-methyladeni
Negative symptoms are a core aspect of psychopathology in schizophrenia. Currently available pharmacological agents have proven minimally efficacious for remediating negative symptoms. A promising treatment avenue is the intranasal administration of the neuropeptide oxytocin. However, there have been inconsistencies in effects of oxytocin on negative symptoms throughout the literature and factors leading to inconsistent effects are unclear. We conducted a systematic review and meta-analysis of RCTs to compare the effectiveness o
Suka
Komentar
Membagikan
